Cancer stem cells (CSCs), a small subset of cells in tumors that are characterized by self-
renewal and continuous proliferation, lead to tumorigenesis, metastasis, and maintain tumor …

Messenger RNA (mRNA) holds great potential in developing immunotherapy, protein
replacement, and genome editing. In general, mRNA does not have the risk of being …

The physiological state of the tumor microenvironment (TME) plays a central role in cancer
development due to multiple universal features that transcend heterogeneity and niche …

Scientists are focusing immense attention on polymeric nanocarriers as a prominent delivery
vehicle for several biomedical applications including diagnosis of diseases, delivery of …

A brain tumor is an uncontrolled cell proliferation, a mass of tissue composed of cells that
grow and divide abnormally and appear to be uncontrollable by the processes that normally …

DNA and RNA vaccines (nucleic acid-based vaccines) are a promising platform for vaccine
development. The first mRNA vaccines (Moderna and Pfizer/BioNTech) were approved in …

COST Action CA17140 Cancer Nanomedicine—from the bench to the bedside
(Nano2Clinic,) is the first, pan-European interdisciplinary network of representatives from …

Short regulatory oligonucleotides are considered prospective tools for immunotherapy.
However, they require an adequate carrier to deliver potential therapeutics into immune …

Simple Summary The resistance of tumours to treatment and their tendency to reoccur
following successful treatment are major problems for long-term cancer patient survival …

Glioblastoma is a rapidly progressing tumor quite resistant to conventional treatment. These
features are currently assigned to a self-sustaining population of glioblastoma stem cells …